Form 4: VolitionRX Executive Ann-Louise Batchelor Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4


Ann-Louise Batchelor, Group Chief Marketing Officer at VolitionRX Ltd, reports changes in her beneficial ownership of company stock due to vesting of restricted stock units (RSUs) and cancellation of unvested RSUs.

Summary

  • On August 15, 2024, Ann-Louise Batchelor, Group Chief Marketing Officer of VolitionRX Ltd, filed a Form 4 to report changes in her beneficial ownership of the company's stock.
  • The report details the vesting of 13,250 restricted stock units (RSUs) awarded on September 28, 2023, under the company's 2015 Stock Incentive Plan.
  • These RSUs vested due to the achievement of certain corporate performance goals.
  • The vested RSUs are subject to a 3-year time-based vesting schedule, with installments vesting on September 28, 2024, 2025, and 2026.
  • Upon vesting and settlement, Batchelor will receive common stock equal to the number of RSUs that have vested.
  • Additionally, 17,225 RSUs that did not meet performance goals were cancelled on August 15, 2024.
  • Following these transactions, Batchelor directly owns 99,549 shares of common stock and indirectly owns 29,406 shares through her spouse.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock ownership changes. The vesting of some RSUs is mildly positive, while the cancellation of others is mildly negative, resulting in a neutral overall sentiment.

Positives

  • The vesting of RSUs indicates that certain corporate performance goals were achieved.

Negatives

  • The cancellation of 17,225 RSUs suggests that some performance goals were not met.

Future Outlook

The reporting person will receive shares of common stock upon the vesting of the RSUs according to the time-based vesting schedule.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track changes in ownership and potential alignment of interests.

Stakeholder Impact

  • Shareholders can monitor insider transactions to gain insights into management's perspective on the company's performance and future prospects.

Next Steps

  • The reporting person will receive shares of common stock as the vested RSUs settle according to the vesting schedule.

Key Dates

DateDescription
09/28/2023Reporting person was awarded 53,000 restricted stock units (RSUs).
12/31/2023Date to achieve certain corporate performance goals for RSU vesting.
01/2024Rights with respect to 22,525 RSUs subject to the award previously vested and remain subject to time-based vesting.
06/30/2024Date to achieve certain corporate performance goals for RSU vesting.
08/15/2024Date of transaction and cancellation of 17,225 unvested RSUs.
08/16/2024Date of report signature.
09/28/2024First installment of time-based vesting of RSUs (4,416 units).
09/28/2025Second installment of time-based vesting of RSUs (4,417 units).
09/28/2026Third installment of time-based vesting of RSUs (4,417 units).

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.